IQVIA Holdings Inc.

193.54-3.22-1.64%Vol 610.40K1Y Perf -14.05%
Mar 22nd, 2023 15:36 DELAYED
BID193.43 ASK193.65
Open196.49 Previous Close196.76
Pre-Market197.00 After-Market-
 0.24 0.12%  - -
Target Price
255.87 
Analyst Rating
Strong Buy 1.28
Potential %
32.06 
Finscreener Ranking
     41.55
Insiders Trans % 3/6/12 mo.
-/-/-33 
Value Ranking
+     34.97
Insiders Value % 3/6/12 mo.
-/-/-96 
Growth Ranking
★★★     51.42
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-96 
Income Ranking
 —    -
Price Range Ratio 52W %
31.16 
Earnings Rating
Sell
Market Cap36.03B 
Earnings Date
26th Apr 2023
Alpha0.01 Standard Deviation0.09
Beta1.33 

Today's Price Range

192.88196.87

52W Range

165.75254.94

5 Year PE Ratio Range

16.00199.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.76%
1 Month
-6.74%
3 Months
-3.14%
6 Months
3.22%
1 Year
-14.05%
3 Years
114.64%
5 Years
93.13%
10 Years
-

TickerPriceChg.Chg.%
IQV193.54-3.2200-1.64
AAPL159.710.43000.27
GOOG105.910.07000.07
MSFT276.042.26020.83
XOM105.51-1.5300-1.43
WFC37.67-0.8150-2.12
JNJ152.35-1.5400-1.00
FB196.640.99000.51
GE90.69-1.4900-1.62
JPM128.45-2.1000-1.61
 
ProfitabilityValueIndustryS&P 500US Markets
34.70
12.90
20.10
4.70
8.10
RevenueValueIndustryS&P 500US Markets
10.67B
57.45
8.82
9.85
Earnings HistoryEstimateReportedSurprise %
Q04 20222.542.540.00
Q03 20222.192.231.83
Q02 20222.212.251.81
Q01 20222.272.343.08
Q04 20212.252.427.56
Q03 20211.992.021.51
Q02 20211.921.941.04
Q01 20211.702.0520.59
Earnings Per EndEstimateRevision %Trend
12/2022 QR2.54-3.42Negative
12/2022 FY9.35-0.53Negative
3/2023 QR2.40-4.76Negative
12/2023 FY10.02-5.74Negative
Next Report Date26th Apr 2023
Estimated EPS Next Report2.21
Estimates Count8
EPS Growth Next 5 Years %9.70
Volume Overview
Volume610.40K
Shares Outstanding186.14K
Shares Float166.97M
Trades Count14.78K
Dollar Volume119.13M
Avg. Volume1.13M
Avg. Weekly Volume1.38M
Avg. Monthly Volume1.11M
Avg. Quarterly Volume893.11K

IQVIA Holdings Inc. (NYSE: IQV) stock closed at 196.76 per share at the end of the most recent trading day (a 2.58% change compared to the prior day closing price) with a volume of 1.06M shares and market capitalization of 36.03B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 77000 people. IQVIA Holdings Inc. CEO is Ari Bousbib.

The one-year performance of IQVIA Holdings Inc. stock is -14.05%, while year-to-date (YTD) performance is -3.97%. IQV stock has a five-year performance of 93.13%. Its 52-week range is between 165.75 and 254.94, which gives IQV stock a 52-week price range ratio of 31.16%

IQVIA Holdings Inc. currently has a PE ratio of 33.40, a price-to-book (PB) ratio of 7.13, a price-to-sale (PS) ratio of 3.63, a price to cashflow ratio of 16.50, a PEG ratio of 2.32, a ROA of 4.90%, a ROC of 8.16% and a ROE of 21.15%. The company’s profit margin is 8.10%, its EBITDA margin is 20.10%, and its revenue ttm is $10.67 Billion , which makes it $57.45 revenue per share.

Of the last four earnings reports from IQVIA Holdings Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.21 for the next earnings report. IQVIA Holdings Inc.’s next earnings report date is 26th Apr 2023.

The consensus rating of Wall Street analysts for IQVIA Holdings Inc. is Strong Buy (1.28), with a target price of $255.87, which is +32.06% compared to the current price. The earnings rating for IQVIA Holdings Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IQVIA Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IQVIA Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.44, ATR14 : 6.63, CCI20 : -78.56, Chaikin Money Flow : 0.09, MACD : -7.10, Money Flow Index : 34.13, ROC : -10.90, RSI : 38.43, STOCH (14,3) : 22.34, STOCH RSI : 1.00, UO : 55.68, Williams %R : -77.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IQVIA Holdings Inc. in the last 12-months were: Eric M. Sherbet (Sold 1 000 shares of value $230 000 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
13 (81.25 %)
12 (80.00 %)
11 (78.57 %)
Moderate Buy
1 (6.25 %)
1 (6.67 %)
1 (7.14 %)
Hold
2 (12.50 %)
2 (13.33 %)
2 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.28
Strong Buy
1.30
Strong Buy
1.32

IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

CEO: Ari Bousbib

Telephone: +1 919 998-2000

Address: 4820 Emperor Boulevard, Durham 27703, NC, US

Number of employees: 77 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

Bearish Bullish

57%43%


News

Stocktwits